Nanopath
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $10M
Investors
- 4
About Nanopath
Based in Massachusetts, US, and founded in 2019 by co-founders Dr. Amogha Tadimety and Dr., aka Nanopath provider of a biosensing platform that diagnoses pelvic and gynecologic infections. Nanopath's technology enables testing for numerous diseases at the same time based on symptoms and delivers test results within 15 minutes. In June 2022, Nanopath Inc. The company's platform uses bioengineering and nanotechnology to detect viral, bacterial, and fungal diseases without the requirement for nucleic acid amplification, allowing doctors to enhance women's health by giving granular and clinically relevant information.
Who invested in Nanopath
4 investors across 1 round
See all investors in Nanopath
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 14, 2022
Amount
$10M
Investors
Questions about Nanopath
Who invested in Nanopath?
Nanopath has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanopath raised?
Nanopath has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanopath last raise money?
Nanopath's most recent round on record is a Series A, in Jun 2022.
What does Nanopath do?
Based in Massachusetts, US, and founded in 2019 by co-founders Dr.
Where is Nanopath headquartered?
Nanopath is headquartered in Cambridge, US.
Which VCs invest in companies like Nanopath?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nanopath's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nanopath? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.